Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paulo Vidal Campregher

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Revista Brasileira De Hematologia E Hemoterapia|October 12, 2014
Does angiogenesis matter in primary myelofibrosis?Paulo Vidal Campregher
Clinical Lymphoma, Myeloma & Leukemia|February 20, 2014
Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practicePaulo Vidal Campregher, Nelson Hamerschlak
Einstein (Sao Paulo, Brazil)|February 7, 2024
A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathwayIsabele Pardo, Pedro Brecheret Fagundes, Rafael Santana de Oliveira, et al.
Einstein (Sao Paulo, Brazil)|February 19, 2026
Mutational signatures in hematological malignanciesFelipe de Almeida Sartori, João Vitor Paes Pontes, Paulo Vidal Campregher, et al.
Arquivos De Neuro-Psiquiatria|April 17, 2013
Primary central nervous system lymphoma: what a neurologist/neurosurgeon should know?Guilherme Fleury Perini, Paulo Vidal Campregher, Fabio Pires de Souza Santos, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Molecular biology of Philadelphia-negative myeloproliferative neoplasmsPaulo Vidal Campregher, Fábio Pires de Souza Santos, Guilherme Fleury Perini, et al.
Einstein (Sao Paulo, Brazil)|March 10, 2016
Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemiaWelbert Oliveira Pereira, Rodolfo Patussi Correia, Nelson Hamerschlak, et al.
International Journal of Hematology|June 15, 2020
Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosisAlexandre Nonino, Paulo Vidal Campregher, Fabio Pires de Souza Santos, et al.
The Oncologist|June 4, 2024
Complete response to capmatinib in a patient with metastatic lung adenocarcinoma harboring CD47-MET fusion: a case reportGlaucia Alves de Souza, Debora Maciel Santana Dornellas, Paulo Vidal Campregher, et al.
Lung Cancer (Amsterdam, Netherlands)|March 4, 2022
EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literatureRubens Copia Sperandio, Francinne Luiza Teixeira Tostes, Paulo Vidal Campregher, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Revista Brasileira De Hematologia E Hemoterapia|October 12, 2014
Does angiogenesis matter in primary myelofibrosis?Paulo Vidal Campregher
Clinical Lymphoma, Myeloma & Leukemia|February 20, 2014
Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practicePaulo Vidal Campregher, Nelson Hamerschlak
Einstein (Sao Paulo, Brazil)|February 7, 2024
A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathwayIsabele Pardo, Pedro Brecheret Fagundes, Rafael Santana de Oliveira, et al.
Einstein (Sao Paulo, Brazil)|February 19, 2026
Mutational signatures in hematological malignanciesFelipe de Almeida Sartori, João Vitor Paes Pontes, Paulo Vidal Campregher, et al.
Arquivos De Neuro-Psiquiatria|April 17, 2013
Primary central nervous system lymphoma: what a neurologist/neurosurgeon should know?Guilherme Fleury Perini, Paulo Vidal Campregher, Fabio Pires de Souza Santos, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Molecular biology of Philadelphia-negative myeloproliferative neoplasmsPaulo Vidal Campregher, Fábio Pires de Souza Santos, Guilherme Fleury Perini, et al.
Einstein (Sao Paulo, Brazil)|March 10, 2016
Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemiaWelbert Oliveira Pereira, Rodolfo Patussi Correia, Nelson Hamerschlak, et al.
International Journal of Hematology|June 15, 2020
Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosisAlexandre Nonino, Paulo Vidal Campregher, Fabio Pires de Souza Santos, et al.
The Oncologist|June 4, 2024
Complete response to capmatinib in a patient with metastatic lung adenocarcinoma harboring CD47-MET fusion: a case reportGlaucia Alves de Souza, Debora Maciel Santana Dornellas, Paulo Vidal Campregher, et al.
Lung Cancer (Amsterdam, Netherlands)|March 4, 2022
EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literatureRubens Copia Sperandio, Francinne Luiza Teixeira Tostes, Paulo Vidal Campregher, et al.
Pageof 5